Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Tuberous Sclerosis 1Thyroid Neoplasms 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphangioleiomyomatosis 1Lipodystrophy, Familial Partial 1Kidney Neoplasms 1Histiocytosis, Non-Langerhans-Cell 1

Interventions

Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pediatric Solid Tumor × Genetic Testing × 1 year × Clear all
NCT02520713 2026-04-28

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Dana-Farber Cancer Institute

Active not recruiting
825 enrolled
Other solid neoplasm

Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡